• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    WNS Announces Addition of Tim Main to Board of Directors

    5/18/21 4:15:00 PM ET
    $WNS
    $DGX
    $JBL
    $SHAC
    Real Estate
    Real Estate
    Medical Specialities
    Health Care
    Get the next $WNS alert in real time by email

    WNS (Holdings) Limited (NYSE:WNS), a leading provider of global Business Process Management (BPM) solutions, today announced the appointment of Timothy L. Main to the company's Board of Directors effective June 1, 2021. Tim has spent his entire career in a B2B services/outsourcing environment, including more than 25 years with Jabil, Inc. (NYSE:JBL), a leading provider of manufacturing services with a global operational footprint. At Jabil, Tim worked his way from a Production Control Manager position to eventually serve as President, Chief Executive Officer, and Chairman of the Board. During his 13-year tenure as Chief Executive Officer of Jabil, he led the company's transformation and growth to a $17+ billion, 100,000 employee organization through organic growth and strategic acquisitions. Tim is currently non-executive Chairman of the Board of Directors and a member of the Cyber Committee at Jabil. In addition, he serves on the Board of Quest Diagnostics (NYSE:DGX) as Chair of the Cybersecurity Committee and a member of the Audit & Finance and Governance committees, and on the Board of SCP & CO Healthcare Acquisition Co. (NASDAQ:SHAC), where he serves as a member of the Audit & Finance Committee.

    "Tim is a proven leader with a distinguished track record in international operations, corporate governance, vision and strategy, and technology-led growth," said Adrian T. Dillon, WNS's Chairman of the Board. "We are pleased to welcome Tim to the WNS Board of Directors, and believe that his experience guiding large organizations and developing talent will be a tremendous asset to the company."

    "The WNS team is delighted to add an experienced executive like Tim to our Board," said Keshav R. Murugesh, Chief Executive Officer of WNS. "His background in leading high-performing teams, driving both organic and inorganic revenue growth, and managing global operations will help WNS continue to generate exceptional value for all of our key stakeholders."

    About WNS

    WNS (Holdings) Limited (NYSE:WNS) is a leading Business Process Management (BPM) company. WNS combines deep industry knowledge with technology, analytics and process expertise to co-create innovative, digitally led transformational solutions with over 375 clients across various industries. WNS delivers an entire spectrum of BPM solutions including industry-specific offerings, customer interaction services, finance and accounting, human resources, procurement, and research and analytics to re-imagine the digital future of businesses. As of March 31, 2021, WNS had 43,997 professionals across 58 delivery centers worldwide including facilities in Australia, China, Costa Rica, India, the Philippines, Poland, Romania, South Africa, Spain, Sri Lanka, Turkey, the United Kingdom, and the United States. For more information, visit www.wns.com.

    Safe Harbor Provision

    This document includes information which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events. Factors that could cause actual results to differ materially from those expressed or implied are discussed in our most recent Form 20-F and other filings with the Securities and Exchange Commission. WNS undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20210518006071/en/

    Get the next $WNS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WNS
    $DGX
    $JBL
    $SHAC

    CompanyDatePrice TargetRatingAnalyst
    Quest Diagnostics Incorporated
    $DGX
    8/25/2025$194.00Outperform → Neutral
    Robert W. Baird
    WNS (Holdings) Limited
    $WNS
    7/17/2025Hold
    Deutsche Bank
    Jabil Inc.
    $JBL
    7/2/2025$245.00Buy
    Stifel
    Jabil Inc.
    $JBL
    6/18/2025Hold → Buy
    Argus
    Quest Diagnostics Incorporated
    $DGX
    4/2/2025$195.00Buy
    Redburn Atlantic
    Quest Diagnostics Incorporated
    $DGX
    3/4/2025$185.00Buy → Neutral
    Citigroup
    Quest Diagnostics Incorporated
    $DGX
    1/6/2025$169.00 → $174.00Market Perform → Outperform
    Leerink Partners
    Quest Diagnostics Incorporated
    $DGX
    12/17/2024$145.00 → $172.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $WNS
    $DGX
    $JBL
    $SHAC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP Chintapalli Anil bought $1,115,226 worth of shares (20,000 units at $55.76), increasing direct ownership by 72% to 47,900 units (SEC Form 4)

    4 - WNS (HOLDINGS) LTD (0001356570) (Issuer)

    6/2/25 4:41:04 PM ET
    $WNS
    Real Estate

    $WNS
    $DGX
    $JBL
    $SHAC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by WNS (Holdings) Limited

    SCHEDULE 13G/A - WNS (HOLDINGS) LTD (0001356570) (Subject)

    11/7/25 11:20:58 AM ET
    $WNS
    Real Estate

    SEC Form 144 filed by Jabil Inc.

    144 - JABIL INC (0000898293) (Subject)

    10/27/25 4:02:02 PM ET
    $JBL
    Electrical Products
    Technology

    SEC Form 15-12G filed by WNS (Holdings) Limited

    15-12G - WNS (HOLDINGS) LTD (0001356570) (Filer)

    10/27/25 8:32:29 AM ET
    $WNS
    Real Estate

    $WNS
    $DGX
    $JBL
    $SHAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and President Davis J. E. covered exercise/tax liability with 7,143 shares, decreasing direct ownership by 6% to 120,480 units (SEC Form 4)

    4 - QUEST DIAGNOSTICS INC (0001022079) (Issuer)

    11/7/25 4:29:54 PM ET
    $DGX
    Medical Specialities
    Health Care

    Executive Chairman Mondello Mark T sold $4,416,554 worth of shares (20,000 units at $220.83), decreasing direct ownership by 2% to 1,228,359 units (SEC Form 4)

    4 - JABIL INC (0000898293) (Issuer)

    11/4/25 4:36:37 PM ET
    $JBL
    Electrical Products
    Technology

    SVP, CHRO Schick Gary K. sold $99,971 worth of shares (453 units at $220.69), decreasing direct ownership by 1% to 42,208 units (SEC Form 4)

    4 - JABIL INC (0000898293) (Issuer)

    11/4/25 4:36:39 PM ET
    $JBL
    Electrical Products
    Technology

    $WNS
    $DGX
    $JBL
    $SHAC
    Leadership Updates

    Live Leadership Updates

    View All

    Eos Energy Enterprises Appoints Industry Veteran John Mahaz as Chief Operating Officer to Drive Next Phase of Operational Growth in American-Made Energy Storage

    EDISON, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ:EOSE) ("Eos" or the "Company"), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS) manufactured in the United States, today announced the appointment of long-time operations leader, John Mahaz, as Chief Operating Officer (COO). Mahaz will lead the Company's operations, supply chain, and manufacturing strategy as Eos enters a critical phase of commercial scale-up. Mahaz joins Eos with more than three decades of experience in global manufacturing, operations, supply chain and business development from his

    8/18/25 8:00:00 AM ET
    $EOSE
    $JBL
    Industrial Machinery/Components
    Miscellaneous
    Electrical Products
    Technology

    Jabil Announces Appointment of New Director to the Board

    Jabil Inc. (NYSE:JBL), a global engineering, supply chain, and manufacturing solutions provider, today announced that Sujatha Chandrasekaran has been appointed to its Board of Directors. "I'm pleased to announce the appointment of Suja to our Board," said Mark Mondello, Jabil's Executive Chairman. "Suja brings with her a terrific leadership style, as well as broad-based experience across relevant end-markets, which position her to become a tremendous asset to our Board." Ms. Chandrasekaran has led global businesses in healthcare, retail, consumer, supply chain and manufacturing with revenues ranging from $3B to $500B. She has most recently served as Senior Executive Vice President, Chief

    4/21/25 8:29:00 AM ET
    $JBL
    Electrical Products
    Technology

    WNS Announces Addition of Sylvie Ouziel to the Board of Directors

    WNS (Holdings) Limited (WNS) ("Company" or "WNS") (NYSE:WNS), a digital-led business transformation and services company, today announced the appointment of Sylvie Ouziel to the Company's Board of Directors effective April 1, 2025. She will also become a member of the Company's Audit Committee. Sylvie brings more than 30 years of experience in building, growing, and leading technology-led global services and software companies. Sylvie is CEO and co-founder of Blue Bridge, an AI-augmented system integration company, and senior business advisor to Univers. Most recently, Sylvie was the CEO of Shared Platforms for Publicis Groupe S.A., one of the world's largest communications groups. She was

    3/12/25 6:00:00 AM ET
    $WNS
    Real Estate

    $WNS
    $DGX
    $JBL
    $SHAC
    Financials

    Live finance-specific insights

    View All

    Quest Diagnostics Declares Quarterly Cash Dividend

    SECAUCUS, N.J., Nov. 11, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.80 per share, payable on January 28, 2026 to shareholders of record of Quest Diagnostics common stock on January 13, 2026. About Quest DiagnosticsQuest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to t

    11/11/25 4:22:00 PM ET
    $DGX
    Medical Specialities
    Health Care

    Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

    Third quarter revenues of $2.82 billion, up 13.1% from 2024Third quarter reported diluted earnings per share ("EPS") of $2.16, up 8.5% from 2024; and adjusted diluted EPS of $2.60, up 13.0% from 2024Year-to-date cash provided by operations of $1.4 billion, up 63.1% from 2024Full year 2025 reported diluted EPS now expected to be between $8.58 and $8.66; and adjusted diluted EPS is expected to be between $9.76 and $9.84SECAUCUS, N.J., Oct. 21, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE:DGX), a leading provider of diagnostic information services, today announced financial results for the third quarter ended September 30, 2025.

    10/21/25 6:45:00 AM ET
    $DGX
    Medical Specialities
    Health Care

    Jabil Declares Quarterly Dividend

    Jabil Inc. (NYSE:JBL) announced that its Board of Directors declared a quarterly dividend of $0.08 per share of common stock to shareholders of record as of the close of business on November 17, 2025. The dividend is payable on December 2, 2025. Jabil has paid consecutive quarterly cash dividends on its common shares since May 15, 2006. About Jabil: At Jabil (NYSE:JBL), we are proud to be a trusted partner for the world's top brands, offering comprehensive engineering, supply chain, and manufacturing solutions. With over 50 years of experience across industries and a vast network of over 100 sites worldwide, Jabil combines global reach with local expertise to deliver both scalable and

    10/17/25 7:30:00 AM ET
    $JBL
    Electrical Products
    Technology

    $WNS
    $DGX
    $JBL
    $SHAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Jabil Inc.

    SC 13G/A - JABIL INC (0000898293) (Subject)

    11/12/24 10:32:13 AM ET
    $JBL
    Electrical Products
    Technology

    Amendment: SEC Form SC 13G/A filed by WNS (Holdings) Limited

    SC 13G/A - WNS (HOLDINGS) LTD (0001356570) (Subject)

    11/1/24 4:27:50 PM ET
    $WNS
    Real Estate

    Amendment: SEC Form SC 13G/A filed by WNS (Holdings) Limited

    SC 13G/A - WNS (HOLDINGS) LTD (0001356570) (Subject)

    7/10/24 10:10:34 AM ET
    $WNS
    Real Estate

    $WNS
    $DGX
    $JBL
    $SHAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quest Diagnostics Declares Quarterly Cash Dividend

    SECAUCUS, N.J., Nov. 11, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE:DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.80 per share, payable on January 28, 2026 to shareholders of record of Quest Diagnostics common stock on January 13, 2026. About Quest DiagnosticsQuest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to t

    11/11/25 4:22:00 PM ET
    $DGX
    Medical Specialities
    Health Care

    Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference

    SECAUCUS, N.J., Nov. 3, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE:DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance and the latest market developments and trends during Citi's 2025 Global Healthcare Conference in Miami on Tuesday, December 2, 2025, at 3:15 p.m. Eastern Time. The fireside chat and Q&A session will be webcast live during the conference on the company's investor relations page, which can be accessed at ir.QuestDiagnost

    11/3/25 4:09:00 PM ET
    $DGX
    Medical Specialities
    Health Care

    New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis

    The Quest AD-Detect® blood-based test panels deliver confirmatory accuracy, potentially supporting reduced reliance on PET-imaging confirmation SECAUCUS, N.J., Oct. 27, 2025 /PRNewswire/ -- Two blood tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer's disease pathology in symptomatic patients, supporting diagnosis, according to a new study in Neurology® Clinical Practice, a publication of the American Academy of Neurology. Conducted by scientists with Quest Diagnostics (NYSE:DGX) and 1Florida ADRC, University of Florida, the study suggests

    10/27/25 7:45:00 AM ET
    $DGX
    Medical Specialities
    Health Care

    $WNS
    $DGX
    $JBL
    $SHAC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Quest Diagnostics downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Quest Diagnostics from Outperform to Neutral and set a new price target of $194.00

    8/25/25 8:10:20 AM ET
    $DGX
    Medical Specialities
    Health Care

    Deutsche Bank resumed coverage on WNS

    Deutsche Bank resumed coverage of WNS with a rating of Hold

    7/17/25 9:22:11 AM ET
    $WNS
    Real Estate

    Stifel resumed coverage on Jabil with a new price target

    Stifel resumed coverage of Jabil with a rating of Buy and set a new price target of $245.00

    7/2/25 7:57:22 AM ET
    $JBL
    Electrical Products
    Technology